Search results
Results From The WOW.Com Content Network
The stock made an attempt to settle below the $140 level.
So there's reason to be optimistic about the company's product approval forecasts, and therefore its revenue potential down the road. And that's why Moderna can be a great investment right now, if ...
In the presentation slides to the U.S. agency, Moderna Inc (NASDAQ:MRNA) shared safety set data, with a cut-off date of March 8, 2024, based on the median of 18.8 months of follow-up.
The stock is trying to settle below $325. For premium support please call: 800-290-4726 more ways to reach us
The FDA notified Moderna that this review may not be completed before January. The company noted that it's committed to conducting its o Why Moderna Shares Are Trading Lower Today
The stock made an attempt to settle below $221. For premium support please call: 800-290-4726 more ways to reach us
GSK Plc (NYSE:GSK) also filed a lawsuit alleging that Moderna's mRNA vaccines infringe on patents it developed. Price Action: MRNA stock is down 1.04% at $41.40 at the last check on Monday. Read Next:
For premium support please call: 800-290-4726 more ways to reach us